Literature DB >> 22518010

Outbreak of transient conversions of the QuantiFERON-TB Gold In-Tube test in laboratory health care worker screenings.

Caterina Zanetti1, Marta Peracchi, Diego Zorzi, Silvia Fiorio, Loredana Fallico, Giorgio Palù.   

Abstract

Gamma interferon release assays were recently introduced in health care worker (HCWs) screenings for tuberculosis surveillance. In longitudinal surveys, conversions and reversions are seen, and yet whether these changes are unspecific or are an expression of new infections and microbial clearance remains unclear. In order to further elucidate these changes, we analyzed an outbreak of 15 transient conversions in 53 HCWs who operate in the same laboratory and handle specimens potentially containing Mycobacterium tuberculosis who underwent screening by the QuantiFERON-TB Gold In-Tube (QFT-GIT) test between 11 May and 30 June 2010: 15/46 (33%) negative HCWs showed a conversion and then reverted after 7 to 107 days. To validate these results, an evaluation of methodological procedures and test reliability, as well as an analysis of results obtained during the same period and processed by the same laboratory, was carried out. For the latter purpose, QFT-GIT results determined for 78 ward HCWs who underwent screening during the same period and were employed in departments with at least 3 infectious tuberculosis patients per year or had cared for an infectious patient without airborne precautions were analyzed with the following results: 6/63 (9%) HCWs with negative results in 3 different departments showed transient conversion (P = 0.002; odds ratio, 4.60; 95% confidence interval, 1.62 to 13.04). A retrospective survey of in-house biosafety practices led to determination of a single exposure factor within the laboratory. These data emphasize the validity of the hypothesis that a transient conversion demonstrates the presence of a real tubercular infection and could be an important indicator for occupational biosafety concerns. They also confirm that subjects with recent conversion should be retested before chest radiography and chemotherapy is offered.

Entities:  

Mesh:

Year:  2012        PMID: 22518010      PMCID: PMC3370442          DOI: 10.1128/CVI.05718-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  27 in total

Review 1.  Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis.

Authors:  R Diel; D Goletti; G Ferrara; G Bothamley; D Cirillo; B Kampmann; C Lange; M Losi; R Markova; G B Migliori; A Nienhaus; M Ruhwald; D Wagner; J P Zellweger; E Huitric; A Sandgren; D Manissero
Journal:  Eur Respir J       Date:  2010-10-28       Impact factor: 16.671

2.  Here today--gone tomorrow: the case for transient acute tuberculosis infection.

Authors:  Edward A Nardell; Robert S Wallis
Journal:  Am J Respir Crit Care Med       Date:  2006-10-01       Impact factor: 21.405

3.  Assessment of Imprecision in gamma interferon release assays for the detection of exposure to Mycobacterium tuberculosis.

Authors:  Tamara Tuuminen; Esko Tavast; Riitta Väisänen; Jaakko-Juhani Himberg; Ilkka Seppälä
Journal:  Clin Vaccine Immunol       Date:  2010-02-24

4.  Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers.

Authors:  Felix C Ringshausen; Albert Nienhaus; José Torres Costa; Heiko Knoop; Stephan Schlösser; Gerhard Schultze-Werninghaus; Gernot Rohde
Journal:  Clin Vaccine Immunol       Date:  2011-05-18

5.  Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.

Authors:  Gerald H Mazurek; John Jereb; Phillip Lobue; Michael F Iademarco; Beverly Metchock; Andrew Vernon
Journal:  MMWR Recomm Rep       Date:  2005-12-16

6.  Estimation of incidence of tuberculosis infection in health-care workers using repeated interferon-gamma assays.

Authors:  T Yoshiyama; N Harada; K Higuchi; Y Nakajima; H Ogata
Journal:  Epidemiol Infect       Date:  2009-05-11       Impact factor: 2.451

7.  T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India.

Authors:  M Pai; R Joshi; S Dogra; A A Zwerling; D Gajalakshmi; K Goswami; M V R Reddy; A Kalantri; P C Hill; D Menzies; P C Hopewell
Journal:  Int J Tuberc Lung Dis       Date:  2009-01       Impact factor: 2.373

8.  Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection.

Authors:  Philip C Hill; Roger H Brookes; Annette Fox; Dolly Jackson-Sillah; David J Jeffries; Moses D Lugos; Simon A Donkor; Ifedayo M Adetifa; Bouke C de Jong; Alex M Aiken; Richard A Adegbola; Keith P McAdam
Journal:  PLoS Med       Date:  2007-06       Impact factor: 11.069

9.  T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data.

Authors:  Anandharaman Veerapathran; Rajnish Joshi; Kalyan Goswami; Sandeep Dogra; Erica E M Moodie; M V R Reddy; Shriprakash Kalantri; Kevin Schwartzman; Marcel A Behr; Dick Menzies; Madhukar Pai
Journal:  PLoS One       Date:  2008-03-26       Impact factor: 3.240

10.  Eliminating latent tuberculosis.

Authors:  Douglas B Young; Hannah P Gideon; Robert J Wilkinson
Journal:  Trends Microbiol       Date:  2009-04-16       Impact factor: 17.079

View more
  2 in total

Review 1.  Early clearance of Mycobacterium tuberculosis: a new frontier in prevention.

Authors:  Ayesha J Verrall; Mihai G Netea; Bachti Alisjahbana; Philip C Hill; Reimout van Crevel
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

Review 2.  MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis.

Authors:  Marielle C Gold; Ruth J Napier; David M Lewinsohn
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.